- Get in Touch with Us
Last Updated: Apr 26, 2025 | Study Period: 2024-2030
When a patient complains of symptoms that could indicate a heart or blood vessel problem, such as shortness of breath, chest pain, chest pressure, heart palpitations, dizziness, sweating, numbness, or weakness, the health care team will perform a battery of tests to diagnose and screen for cardiovascular conditions.
A cardiac condition is usually diagnosed using a combination of blood testing, heart monitoring, and imaging examinations.
Cardiovascular diagnostic and screening tests can reveal a wealth of information about the electrical activity of the heart, heartbeat rhythm, how well blood is pumping through the chambers and valves of the heart, how easily blood flows through the coronary arteries to the heart muscle, and whether there are tumors or abnormalities in the cardiovascular system's structure.
Some tests can even record heart activity, providing clinicians with crucial information regarding whether activities such as exercise or lying down are contributing reasons to symptoms.
An electrocardiogram (ECG) is a rapid and painless examination that captures electrical impulses in the heart. It can detect whether the heart is beating too quickly or too slowly.
A Holter monitor is a portable ECG device that is worn for a day or longer to record the activity of the heart during daily activities. This test can detect irregular heartbeats that a standard ECG cannot.
This noninvasive scan creates precise pictures of the heart in action using sound waves. It depicts how blood flows through the heart and its valves. An echocardiography can assist in detecting if a patient has a heart condition.
These tests sometimes entail walking on a treadmill or riding a stationary bike while having the heart rate monitored.
Exercise testing can indicate how the heart responds to physical activity and whether or not symptoms of heart disease arise during exercise. This test can detect cardiac artery blockages.
A catheter is a long, thin, flexible tube that is placed into a blood artery, often in the groin or wrist, and directed to the heart.
Dye is delivered to arteries in the heart through the catheter. The dye makes the arteries more visible on X-ray pictures acquired during the exam.
A cardiac MRI creates comprehensive pictures of the heart by using a magnetic field and computer-generated radio waves.
Cardiovascular disease refers to a range of illnesses that affect heart and blood arteries. These conditions can affect one or more components of the heart or blood arteries.
A person might be symptomatic (feeling the disease physically) or asymptomatic (not feeling anything at all).
Cardiovascular disease refers to heart or blood vessel problems, such as Blood vessel constriction in heart, other organs, or throughout the body.
Heart and blood vascular issues appear at birth.Heart valves that aren't functioning properly.
Heart rhythm irregularities. Almost half of all individuals in the United States suffer from some sort of cardiovascular disease.
People of various ages, genders, races, and socioeconomic backgrounds are affected. Cardiovascular disease kills one in every three women and persons designated female at birth.
The causes of cardiovascular disease differ depending on the kind. Coronary artery disease and peripheral artery disease, for example, are caused by atherosclerosis (plaque accumulation in arteries).
Arrhythmias can be caused by coronary artery disease, scarring of the heart muscle, hereditary issues, or drugs. Valve disorders can be caused by aging, infections, or rheumatic illness.
The symptoms of cardiovascular disease might vary depending on the etiology.
Older persons and people born female may experience more modest symptoms. They can, however, develop significant cardiovascular disease.
A problem with the electrical conduction system of the heart, which can result in irregular cardiac rhythms or heart rates.
Heart valves may be tightening or leaking. A problem with the heart's pumping and relaxing processes, resulting in fluid accumulation and shortness of breath.
Blockages in the heart's blood arteries are an example of a problem.
The Global Cardiovascular Diagnostics Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
PrecisionCHD, an integrated epigenetic-genetic blood test for the early diagnosis of coronary heart disease, was launched by Cardio Diagnostics Holdings.
PrecisionCHD is the second clinical test that employs the Chicago-based company's AI-enabled Integrated Epigenetic-Genetic Engine.
Epi+Gen CHD, its first product, is a three-year coronary heart disease risk assessment test.The two tests estimate the risk of coronary heart disease, the most prevalent kind of cardiovascular illness, for both prevention and early detection.
Cardio Diagnostics aims to continue using its AI-based technology over the next two years to create a range of integrated epigenetic-genetic clinical tests for different cardiovascular illnesses and related ailments.
According to Cardio Diagnostics, PrecisionCHD diagnoses coronary heart disease with% sensitivity in both men and women.
The test employs epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) indicators in conjunction with a machine-learning model established through the analysis of billions of genomic and epigenomic data points.
The technology is integrated with a clinical intelligence platform that correlates a patient's unique biomarker profile with modifiable risk factors such as diabetes, hypertension, hypercholesterolemia, and smoking â all of which are major contributors to coronary heart disease.
Clinicians attempting to determine the state of coronary heart disease in their patients no longer have to be concerned about their capacity to acquire an exercise stress test or angiography.
| Sl no | Topic |
| 1 | Market Segmentation |
| 2 | Scope of the report |
| 3 | Abbreviations |
| 4 | Research Methodology |
| 5 | Executive Summary |
| 6 | Introduction |
| 7 | Insights from Industry stakeholders |
| 8 | Cost breakdown of Product by sub-components and average profit margin |
| 9 | Disruptive innovation in the Industry |
| 10 | Technology trends in the Industry |
| 11 | Consumer trends in the industry |
| 12 | Recent Production Milestones |
| 13 | Component Manufacturing in US, EU and China |
| 14 | COVID-19 impact on overall market |
| 15 | COVID-19 impact on Production of components |
| 16 | COVID-19 impact on Point of sale |
| 17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
| 18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
| 19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
| 20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
| 21 | Product installation rate by OEM, 2023 |
| 22 | Incline/Decline in Average B-2-B selling price in past 5 years |
| 23 | Competition from substitute products |
| 24 | Gross margin and average profitability of suppliers |
| 25 | New product development in past 12 months |
| 26 | M&A in past 12 months |
| 27 | Growth strategy of leading players |
| 28 | Market share of vendors, 2023 |
| 29 | Company Profiles |
| 30 | Unmet needs and opportunity for new suppliers |
| 31 | Conclusion |
| 32 | Appendix |
© 2017-2026 Mobility Foresights Pvt Ltd. All rights reserved.
Developed with by ClousTech